Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 23, 2016 ) "DP1 Receptor (Prostaglandin D2 receptor) Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the DP1 Receptor (Prostaglandin D2 receptor) Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for DP1 Receptor (Prostaglandin D2 receptor) Antagonists. DelveInsight's Report also assesses the DP1 Receptor (Prostaglandin D2 receptor) Antagonists therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
For more information http://www.reportsweb.com/dp1-receptor-prostaglandin-d2-receptor-antagonists-pipeline-insights-2016
Table of Contents
- DP1 Receptor (Prostaglandin D2 receptor) Antagonists Overview - DP1 Receptor (Prostaglandin D2 receptor) Antagonists Disease Associated - DP1 Receptor (Prostaglandin D2 receptor) Antagonists Pipeline Therapeutics - DP1 Receptor (Prostaglandin D2 receptor) Antagonists Therapeutics under Development by Companies - DP1 Receptor (Prostaglandin D2 receptor) Antagonists Filed and Phase III Products - Comparative Analysis - DP1 Receptor (Prostaglandin D2 receptor) Antagonists Phase II Products - Comparative Analysis - DP1 Receptor (Prostaglandin D2 receptor) Antagonists Phase I and IND Filed Products - Comparative Analysis - DP1 Receptor (Prostaglandin D2 receptor) Antagonists Discovery and Pre-Clinical Stage Products - Comparative Analysis - Drug Candidate Profiles - DP1 Receptor (Prostaglandin D2 receptor) Antagonists - Therapeutics Assessment - Assessment by Monotherapy Products - Assessment by Combination Products - Assessment by Route of Administration - Assessment by Molecule Type - DP1 Receptor (Prostaglandin D2 receptor) Antagonists - Discontinued Products - DP1 Receptor (Prostaglandin D2 receptor) Antagonists - Dormant Products - Companies Involved in Therapeutics Development for DP1 Receptor (Prostaglandin D2 receptor) Antagonists - Appendix - Methodology - Contact Us - Disclaimer
Request Sample Copy http://www.reportsweb.com/inquiry&RW000184305/sample
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|